Pratik Shah, Ph.D., is a distinguished leader in the biotechnology industry, currently serving as the President, Chief Executive Officer, and Chairperson at Design Therapeutics Inc. Dr. Shah's academic journey began with a Bachelor of Science in Biochemistry from the University of California, Berkeley, followed by a Ph.D. in Chemistry from the California Institute of Technology (Caltech). His expertise in biochemistry and chemistry has been pivotal in steering Design Therapeutics towards groundbreaking advancements in genetic medicine. Before joining Design Therapeutics, Dr. Shah held significant roles at leading biotech firms, including positions at Genentech and Amgen, where he was instrumental in the development and commercialization of novel therapeutics. His tenure at these companies honed his skills in strategic leadership and innovation, culminating in multiple successful drug launches that have had a profound impact on patient care. At Design Therapeutics, Dr. Shah leverages his extensive experience to guide the company's mission of developing treatments for serious genetic diseases through its proprietary GeneTAC™ platform. Under his leadership, the company has made significant strides in advancing its pipeline of potential therapies, aiming to address unmet medical needs and improve the lives of patients worldwide. In his role as President, CEO, and Chairperson, Dr. Shah is responsible for overseeing the overall strategy and operations of Design Therapeutics. His visionary approach has fostered a culture of innovation and collaboration within the organization, driving the development of novel gene-targeted small molecules. Dr. Shah's leadership has been crucial in securing partnerships and investments that support the company's growth and research endeavors. His dedication to advancing genetic medicine continues to position Design Therapeutics at the forefront of the biotechnology industry, with a clear focus on translating scientific discoveries into life-changing treatments.